The factor VIII that is packaged in Weibel-Palade bodies is produced largely in the endothelial cells, rather than in the liver alongside the other coagulation factors, as previously thought.

Due to their role in hemostasis, inflammation, and angiogenesis, it has been proposed that targeted inhibitors of exocytosis could treat inflammatory or thrombotic conditions